TABLE 2.
Coefficients from regression models of health outcomes in 2003 on DHEAS in 2000a, unweighted analyses
| Mobility Limitations | CES-D | Cognitive Impairment | Poor Self-Assessed Health | |||||
|---|---|---|---|---|---|---|---|---|
| (1) | (2) | (1) | (2) | (1) | (2) | (1) | (2) | |
| DHEAS (μg/dl): Femalesb | 0.0009 | 0.0010 | 0.0044 | 0.0041 | −0.0016 | −0.0017 | 0.0006 | 0.0006 |
| DHEAS squared: Femalesb | -- | -- | -- | -- | 0.000008 | 0.000008 | -- | -- |
| DHEAS (μg/dl): Maleb | −0.0030**c | 0.0032**c | −0.0082* | −0.0088* | −0.0016*** | −0.0016*** | −0.0019 | −0.0022* |
| DHEAS squared: Maleb | -- | -- | -- | -- | 0.000005*** | 0.00005*** | -- | -- |
| Cortisol (μg/g creatinine) | −0.0014 | −0.0012 | 0.0016 | −0.0008 | −0.0002 | −0.0002 | 0.0016 | 0.0011 |
| Cortisol squared | 0.00001* | 0.00001* | -- | -- | -- | -- | -- | -- |
*
p<0.05;
**
p<0.01;
***
p<0.001
a
Models are fitted using linear regression for the depressive symptom score, Poisson regression for cognitive impairment, zero-inflated Poisson regression for mobility limitations, and ordered logistic regression for self-assessed health status. Both models includes the control variables, while Model 2 also adjusts for cardiovascular risk factors (see Table 1).
b
For variables with sex interactions, we show the total effect for males (equivalent to the main effect) and females (equivalent to the sum of the main and the interaction effect).
c
Sex difference in the parameter estimate is significant (p<0.05).